MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma

• Yasuo Takashima,

  Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Supervision, Writing – original draft, Writing – review & editing

  Affiliation Laboratory of Molecular Target Therapy for Cancer, Graduate School for Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

  http://orcid.org/0000-0001-8876-6673

  ⨯
• Atsushi Kawaguchi,

  Roles Formal analysis, Investigation, Methodology, Supervision, Writing – original draft, Writing – review & editing

  Affiliation Center for Comprehensive Community Medicine, Faculty of Medicine, Saga University, Saga, Japan

  ⨯
• Yasuo Iwadate,

  Roles Resources

  Affiliation Department of Neurosurgery, Graduate School of Medical Sciences, Chiba University, Chiba, Japan

  ⨯
• Hiroaki Hondoh,

  Roles Resources

  Affiliation Departments of Neurosurgery, Toyama Prefectural Central Hospital, Toyama, Japan

  ⨯
• Junya Fukai,

  Roles Resources

  Affiliation Department of Neurological Surgery, Wakayama Medical University School of Medicine, Wakayama, Japan

  http://orcid.org/0000-0001-7103-8493

  ⨯
• Koji Kajiwara,

  Roles Resources

  Affiliation Department of Neurosurgery, Graduate School of Medical Sciences, Yamaguchi University, Ube, Yamaguchi, Japan

  ⨯
• Azusa Hayano,

  Roles Investigation

  Affiliation Laboratory of Molecular Target Therapy for Cancer, Graduate School for Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

  ⨯
• Ryuya Yamanaka

  Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: ryaman@koto.kpu-m.ac.jp

  Affiliation Laboratory of Molecular Target Therapy for Cancer, Graduate School for Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

  ⨯